Evidence map›Paper›PMID 15272075›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.

Kate E Lawlor, Ian K Campbell, Donald Metcalf, Kristy O'Donnell, Annemarie van Nieuwenhuijze, Andrew W Roberts, Ian P Wicks

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 121 citations in OpenAlex.

  1. Trial
  2. Sex Differences in Lung B Cell Responses in a Murine Model of Asthma.International archives of allergy and immunology · 2026
    Article
  3. Article
  4. Activation of the proton-sensing GPCR, GPR65 on fibroblast-like synoviocytes contributes to inflammatory joint pain.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Leukotriene BBiomedicines · 2022
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Kate E LawlorThe Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3050, Australia.
Ian K Campbell
Donald Metcalf
Kristy O'Donnell
Annemarie van Nieuwenhuijze
Andrew W Roberts
Ian P Wicks
Walter and Eliza Hall Institute of Medical Research · AU

Funding

Differentiation of Granulocytes and MacrophagesR37CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 2005 to 2014
$2.3M
DIFFERENTIATION OF GRANULOCYTES AND MACROPHAGESR01CA022556 · NCI · WALTER AND ELIZA HALL INST MEDICAL RES · PI METCALF, DONALD · 1985 to 2004
$900k
NCI NIH HHS CA22556NCI NIH HHS R01 CA022556NCI NIH HHS R37 CA022556
6 · The paper itself

Abstract

Granulocyte colony-stimulating factor (G-CSF) is a well known regulator of granulopoiesis, but the role of endogenous G-CSF in inflammatory joint disease has not been explored. We studied the response of G-CSF-deficient mice in experimental models of joint inflammation. We show that G-CSF deficiency protects mice from acute and chronic arthritis. Reduced severity was associated with blunted mobilization of granulocytic cells from the bone marrow and less cellular infiltrate and cellular activation in inflamed joints. We also demonstrate that G-CSF blockade in established collagen-induced arthritis in WT mice markedly reduces disease manifestations and is as effective as tumor necrosis factor blockade. Our results reveal a critical role for G-CSF in driving joint inflammation and highlight G-CSF as a potential therapeutic target in inflammatory joint diseases, such as rheumatoid arthritis.

Indexed as

Acute DiseaseAnimalsAntibodies, MonoclonalAntigen PresentationArthritis, ExperimentalArthritis, RheumatoidChronic DiseaseCollagen Type IIDisease Models, AnimalFreund's AdjuvantGranulocyte Colony-Stimulating FactorGranulocytesInterleukin-1MiceMice, Inbred C57BLMice, Inbred DBAAntibodies, MonoclonalCollagen Type IIFreund's AdjuvantGranulocyte Colony-Stimulating FactorInterleukin-1

Identifiers

PMID15272075
PMCPMC509212
OpenAlexW2130859054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.